Musculoskeletal (MSK) Disease Management Market is Likely to Upsurge CAGR of 22.8% by 2030
Global Musculoskeletal (MSK) Disease Management Market report is an excellent report that makes it possible to the HEALTHCARE industry to take strategic decisions and achieve growth objectives. HEALTHCARE industry can be highly benefited with this market research report which brings market and competitive landscape clearly into the focus and help make better decisions. In this business document, market segmentation has also been performed in detail based on various parameters that include applications, verticals, deployment model, end user, and geography. Expert solutions combined with potential capabilities make Global Musculoskeletal (MSK) Disease Management Market survey report outperforming for the HEALTHCARE industry.
The increasing demand for technological advancements in the diagnosis of MSK diseases, rising awareness about MSK diseases, growing prevalence of Rheumatoid Arthritis (RA) and increasing cases of bone fractures are the factors expected to drive the market growth.
Market Development
- In 2022, DarioHealth Corp. and Sanofi U.S. entered into a contract. The development of Digital Health Solutions on the DarioHealth Corp. platform and the acceleration of commercial growth for DarioHealth Corp.’s MSK disease management digital portfolio were the main focuses of the agreement.
- In 2022, Airrosti Rehab Center, LLC formed a partnership with Buoy Health’s innovative healthcare marketplace. The partnership resulted to bring good value MSK care to Buoy’s more than 2 million users per month and the development of novel MSK virtual products.
- In 2021, SpineZone declared an investment of USD 12.00 million in series A funding to integrate virtual and in-person (telemedicine) MSK care. The investment made is expected to expand the product and business footprint across North America and Europe with new funds.
- In 2021, IncludeHealth launched the MSK operating system for virtual physical therapy. The MSK operating system provides an integrated virtual and in-person care telehealth experience.
- In 2020, Omada Health, Inc. acquired Physera, a MSK care company, which delivers muscular intervention via remote telehealth services. The acquisition allowed the addition of Physera’s MSK solutions to the product portfolio, which resulted in the expansion of the product range.
Major Players
Data Bridge Market Research recognizes the following companies as the major musculoskeletal (MSK) disease management market players in musculoskeletal (MSK) disease management market are RecoveryOne (U.S.), Kiio (U.S.), Omada Health Inc. (U.S.), DarioHealth Corp. (U.S.), IncludeHealth (U.S.), kaia health (Germany), IMC. (U.S.), Wellness Coaches USA, LLC (U.S.), Sparta Science (U.S.)Movement RX (U.S.)
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-musculoskeletal-msk-disease-management-market&Shri
The rising demand for use of MSK disease management in drug development and design is expected to drive market growth in the global scenario. Data Bridge Market Research analyzes that the global musculoskeletal (MSK) disease management market will grow at a CAGR of 22.8% during the forecast period of 2023 to 2030.
Market Definition
Musculoskeletal (MSK) disease or impairments comprise more than 150 different diseases or conditions, which internally affect the human system and are characterized by deficiencies in the muscles, bones, joints and adjacent connective tissues, which lead to lifelong hindrances in functioning and participation. The conditions are characterized by pain, limited gait movement and dexterity thereby, reducing people’s aptitude to work and participate in society.
The management of MSK diseases involves consultation with a physician, integrated with telemedicine, which is the use of Digital Biofeedback Systems (DBSs), MDAs and therapies. Physical activity and weight management programs are also important self-management activities for persons with arthritis. Virtual therapy or remote consultation entails a holistic approach with the implementation of video conference and phone consultations in MSK practice.
Rising healthcare expenditure is expected to drive the market’s growth rate
The global Musculoskeletal (MSK) Disease Management market is experiencing growth due to the rising healthcare expenditure worldwide. Factors such as population growth, economic development, and the need for better healthcare infrastructure have led to increased investments in MSK disease management programs. Governments and private entities are recognizing the economic burden of these conditions and are focusing on improving patient outcomes. This increased investment in MSK disease management contributes to the market’s growth by providing better resources and care for individuals with MSK diseases.
Report Scope and Market Segmentation
| Report Metric | Details |
| Forecast Period | 2023 to 2030 |
| Base Year | 2022 |
| Historic Years | 2021 (Customizable to 2015-2020) |
| Quantitative Units | Revenue in USD Million, Volumes in Units, Pricing in USD |
| Segments Covered | Type (Digital Biofeedback System, Musculoskeletal-focused Digital Apps, Solutions and Others), Technology (Precision Motion Technology, Computer Vision Technology and Other Technologies), Integration Type (Phone, Tablet, Computer and Others), Modality (Virtual Therapy, In-Person Therapy, Customized/Personalized Therapy and Others), Application (Pre-Surgery Applications and Post-Surgery Applications), Patient Population (Pediatrics, Adults and Geriatrics), End User (Hospitals and Clinics, Nursing Homes, Health Centers, Rehabilitation Centres, Virtual/Home Health Care Settings and Others) |
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-musculoskeletal-msk-disease-management-market?Shri
Segment Analysis:
The musculoskeletal (MSK) disease management market is segmented on the basis of type, technology, integration type, modality, application, patient population and end user
- On the basis of type, the market is segmented into digital biofeedback system, musculoskeletal-focused digital apps (MDAs), solutions, and others. In 2023, the digital biofeedback system segment is expected to dominate the market with a CAGR of 23.4% in the forecast period of 2023 to 2030 due to to better potency, improved compliance, ease of convenience. The digital biofeedback systems provide rehabilitation and providing the users with customized guidance and gives the ability to practice new ways to control the body to improve physical performance.
- On the basis of technology, the market is segmented into precision motion technology, computer vision technology, and other technologies. In 2023, the precision motion technology segment is expected to dominate the market with a market share of 59.45% in the forecast period of 2023 to 2030 due to manufacturing, robotics, medical devices, and aerospace, where precise positioning, control, and accuracy are essential.
In 2023, the precision motion technology segment is expected to dominate the technology segment of the market
In 2023, the precision motion technology segment is expected to dominate the market owing to the use of high-precision components, sensors, and control systems to achieve accurate motion control for enhanced performance and productivity with a market share of 59.45% in the forecast period of 2023 to 2030.
- On the basis of integration type, the market is segmented into phone, tablet, computers, and others. In 2023, the phone segment is expected to dominate the market with a CAGR of 23.4% in the forecast period of 2023 to 2030 due to specific features or applications in smartphones to enhance functionality or provide additional services.
- On the basis of modality, the market is segmented into virtual therapy, in-person therapy, customized/personalized therapy, and others. In 2023, the virtual therapy segment is expected to dominate the market with a CAGR of 23.5% in the forecast period of 2023 to 2030 due to improvements in pain management, gait, physical function, rise in patient population, and improved patient outcomes, which are expected to drive segment growth
- On the basis of application, the market is segmented into pre-surgery applications, post-surgery applications, and others. In 2023, the pre-surgery application segment is expected to dominate the market with a market share of 54.02%. In the forecast period of 2023 to 2030 due to medical imaging scans, such as MRI or CT scans. These applications provide tools for visualizing and measuring anatomical structures, identifying potential surgical targets, and simulating surgical procedures.
- On the basis of the patient population, the market is segmented into paediatrics, adults, and geriatrics. In 2023, the pediatrics segment is expected to dominate the market with a CAGR of 23.2% in the forecast period of 2023 to 2030 due to a wide range of medical specialties, including preventive care, immunizations, developmental assessment, and management of chronic conditions specific to this age group.
In 2023, the pediatrics segment is expected to dominate the patient population segment of the market
In 2023, the pediatrics segment is expected to dominate the patient population segment of the market owing to the wide range of medical specialties, including preventive care, immunizations, developmental assessments, treatment of common childhood illnesses, and management of chronic conditions specific to this age group with a CAGR of 23.2% in the forecast period of 2023 to 2030
- On the basis of end-user, the market is segmented into hospitals and clinics, nursing homes, health centers, rehabilitation centers, virtual/home healthcare settings, and others. In 2023, the hospitals and clinics segment is expected to dominate the market with a CAGR of 23.7% in the forecast period of 2023 to 2030 due to emergency care, surgeries, diagnostics, inpatient care, outpatient care, and specialized treatments. They are equipped with medical professionals, advanced technologies, and various departments to cater to diverse healthcare needs.
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Fundamental Aim of this Market Report
- Notable Market rivals around the world.
- Future Scope and Product Outlook
- Future-promising emerging markets.
- The Market Presents Difficult Challenges and Threats.
Key highlights of this Market report:
- Major restraints
- Market drivers
- Regional bifurcation
- Competitive hierarchy
- Current market tendencies
- Market concentration analysis
Table of figures:
TABLE 1 GLOBAL MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 2 GLOBAL DIGITAL BIOFEEDBACK SYSTEM IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 GLOBAL MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 8 GLOBAL POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 9 GLOBAL OTHERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 GLOBAL MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
Continued…
Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=global-musculoskeletal-msk-disease-management-market&Shri
Critical Insights Related to the adalimumab biosimilar Included in the Report:
-
- Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market
- Value chain analysis of prominent players in the market
- Current trends influencing the dynamics of this market across various geographies
- Recent mergers, acquisitions, collaborations, and partnerships
- Revenue growth of this industry over the forecast period
- Marketing strategy study and growth trends
- Growth-driven factor analysis
- Emerging recess segments and region-wise market
- An empirical evaluation of the curve of this market
- Ancient, Present, and Probable scope of the market from both prospect value and volume
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
